Immunic

Immunic is a clinical-stage biopharmaceutical company developing selective oral immunology therapies for chronic inflammatory and autoimmune diseases. 

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Astellas appoints new top strategist—Chutes & Ladders

Astellas appoints new top strategist from Sanofi Japan. Immunic preps for approval push with pharma vet. Cardiologist turns new leaf at Nuevocor.
arrow miss target fail attempt try

Immunic MS asset misses primary goal of midstage trial

Apr 30, 2025 3:05pm
Alzheimers brain

Immunic's investors appeased by biomarker data from MS trial

Oct 10, 2023 9:35am
change direction new plan alter arrows move reprioritize

Immunic punts psoriasis and prostate programs to narrow focus

Apr 5, 2023 9:05am
Nasdaq

Dreaded 'high placebo rate' hits Immunic's psoriasis trial

Oct 21, 2022 8:00am
money and shares declining

Immunic regains some momentum with multiple sclerosis update

Jun 15, 2022 9:35am